Biopharmaceuticals to gene therapy

Part 1 book "Animal cell technology, from biopharmaceuticals to gene therapy" includes content: Introduction to animal cell technology, animal cells - basic concepts, cloning and expression of heterologous proteins in animal cells, cell metabolism and its control in culture, culture media for animal cells, post-translational modification of recombinant proteins, mechanisms of cell proliferation and cell death in animal cell culture in vitro, mathematical models for growth and product synthesis in animal cell culture.

259p oursky05 20-09-2023 6 2   Download

Part 2 book "Animal cell technology, from biopharmaceuticals to gene therapy" includes content: Bioreactors for animal cells, monitoring and control of cell cultures, animal cell separation, product purification processes, quality control of biotechnological products, regulatory aspects, intellectual property, recombinant therapeutic proteins, monoclonal antibodies, viral vaccines - concepts, principles, and bioprocesses, bioinsecticides, cell therapies and stem cells, gene therapy.

306p oursky05 20-09-2023 4 2   Download

Cutaneous adverse reactions (CARs) from antiepileptic drugs (AEDs) are common, ranging from mild to life-threatening, including Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The identification of subjects carrying the HLA-B*15:02, an inherited allelic variant of the HLAB gene, and the avoidance of carbamazepine (CBZ) therapy in these subjects are strongly associated with a decrease in the incidence of carbamazepine-induced SJS/TEN. In spite of the strong genetic associations, the initiation of hypersensitivity for AEDs is still not very well characterized.

10p caothientrangnguyen 09-05-2020 10 1   Download